Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-γ-Dependent Innate Immunity

Louisa Varinou, Katrin Ramsauer, Marina Karaghiosoff, +4

Immunity

CytokineSignal TransductionImmune Cell DevelopmentViral ImmunityImmunology +10

Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1

Gordin Zupkovitz, Julia Tischler, Markus Posch, +8

Molecular and Cellular Biology

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas, +7

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentFirst-in-man Trial +4

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Timothy Pepini, Anne-Marie Pulichino, Thomas Carsillo, +10

The Journal of Immunology

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler, +7

The Lancet

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunology +4

p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation

Katrin Ramsauer, Iwona Sadzak, Almudena Porrás, +4

Proceedings of the National Academy of Sciences

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible<i>gbp2</i>gene

Katrin Ramsauer, Matthias Farlik, Gordin Zupkovitz, +4

Proceedings of the National Academy of Sciences

Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons

Andreas Pilz, Katrin Ramsauer, Hamid Reza Heidari, +3

EMBO Reports

CytokineSignal TransductionSignaling PathwayStat1 Transactivating DomainNatural Sciences +7

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

Shannan L. Rossi, Jason E. Comer, Eryu Wang, +6

The Journal of Infectious Diseases

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

Roland Tschismarov, Pierre Van Damme, Clara Germain, +13

The Lancet

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology +3